Home › Funds › ProVise Management Group, LLC › ELV
ProVise Management Group, LLC position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
ProVise Management Group, LLC reported holding 29,275 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 0.78% of its reported portfolio and ranking #41 among its reported holdings. ProVise Management Group, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ProVise Management Group, LLC's ELV position evolved
ProVise Management Group, LLC first disclosed a stake in ELV in Q3 2023 at 16,769 shares (US$7.3M). The position peaked in Q2 2024 at 21,202 shares, worth US$11.5M. Across 13 filings, ProVise Management Group, LLC increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 29,275 shares valued at US$11.4M — an increase of 3,094 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 16.77K | $7.30M | New |
| Q4 2023 | 18.96K | $8.94M | Add |
| Q1 2024 | 20.77K | $10.77M | Add |
| Q2 2024 | 21.20K | $11.49M | Add |
| Q3 2024 | 21.81K | $11.34M | Add |
| Q4 2024 | 17.14K | $6.32M | Reduce |
| Q1 2025 | 20.25K | $8.81M | Add |
| Q2 2025 | 23.52K | $9.15M | Add |
| Q3 2025 | 23.07K | $7.45M | Reduce |
| Q4 2025 | 25.00K | $8.77M | Add |
| Q1 2026 | 26.18K | $7.66M | Add |
| Q2 2026 | 26.18K | $10.12M | Hold |
| Q3 2026 | 29.27K | $11.38M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on ProVise Management Group, LLC
FAQ
How long has ProVise Management Group, LLC held ELV?
ProVise Management Group, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ProVise Management Group, LLC's current position in ELV?
As of Q3 2026, ProVise Management Group, LLC holds 29.27K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $11.38M, representing 0.78% of its reported portfolio and ranking #41.
Has ProVise Management Group, LLC been buying or selling ELV?
In the latest 13F filing (Q3 2026), ProVise Management Group, LLC increased its position in ELV. The position peaked in Q2 2024 at 21.20K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.